Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway.
about
Chemoresistance in human ovarian cancer: the role of apoptotic regulators"Ziziphus jujuba": A red fruit with promising anticancer activitiesChemoresistance and targeted therapies in ovarian and endometrial cancersCytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancerCell fate regulation by gelsolin in human gynecologic cancers.Regulation of inflammation by the NF-κB pathway in ovarian cancer stem cells.Luteolin induces carcinoma cell apoptosis through binding Hsp90 to suppress constitutive activation of STAT3.Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?Novel agents in epithelial ovarian cancer.Targeted therapy for epithelial ovarian cancer.Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.MTRR silencing inhibits growth and cisplatin resistance of ovarian carcinoma via inducing apoptosis and reducing autophagy.Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cellsRegulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by AktNovel agents in ovarian cancer.Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancerRapamycin by itself and additively in combination with carboplatin inhibits the growth of ovarian cancer cellsBithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway.Transformation of human ovarian surface epithelial cells by Krüppel-like factor 8.MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP.Activation of KLF8 transcription by focal adhesion kinase in human ovarian epithelial and cancer cells.Induction of cIAP-2 in human colon cancer cells through PKC delta/NF-kappa B.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Molecular diagnosis and molecular profiling to detect treatment-resistant ovarian cancer.Inhibition of survivin restores the sensitivity of breast cancer cells to docetaxel and vinblastine.Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.ERK1/2 and Akt pathway activated during (3R,6R)-bassiatin(1)-induced apoptosis in MCF-7 cells.Phosphatidylinositol 3-kinase-C2β inhibits cisplatin-mediated apoptosis via the Akt pathway in oesophageal squamous cell carcinoma.Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro.Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP).Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein.Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients.Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts.A literature mining-based approach for identification of cellular pathways associated with chemoresistance in cancer.Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer.Natural products: a hope for glioblastoma patients.
P2860
Q24791433-DC333C57-276A-4D45-9E92-91D65C8AC727Q26782533-855061A7-E925-417D-A2E6-943821EA6418Q28073246-76B991D0-92B3-4C07-9710-152E154F3511Q34024735-4EDD1A3B-5293-4C8A-9DBC-C8D73697F0A1Q34407454-A9C680C4-58A0-4296-BFA7-F6FC4BC7F3EAQ34424820-FD2FB06B-20C5-4B04-AF46-52D6349327E6Q34474233-FDD06862-D803-41F0-AA28-209751CE01BBQ34528724-7D10AEA3-CDF1-4BBA-9174-7C99974BE9D3Q35905166-7E6A8FA3-A588-4375-AEC0-0C9CA23D4C1BQ35968752-0B309E22-2890-4039-B43E-1227EB4470D3Q36158708-B0A0D306-0091-4EED-9AE6-35AE6B59237FQ36180735-0F253A75-9509-4698-89A4-085BB012B507Q36225822-6DB268F3-3C2A-4C9E-86E3-EA85BD1AD87BQ36265840-D3C38A5E-1368-40E8-B512-9E3135D2628DQ36484510-ED23719F-DF4B-4B92-812F-B9B1FAB49737Q36904860-8349E1CD-0A26-4403-8E48-1D39947FF9B9Q37257188-0164FACC-F229-415F-B3C0-9C4596041173Q37301601-997AC1BF-C74E-4E97-ACFC-5852647BFA46Q37580909-6E8ED4B6-1845-48A8-971A-714988D4EC37Q37652592-A5BC88A4-F9BE-484E-A0EA-240A9FC579DEQ37685062-8D174E67-19B5-4BB7-975A-7BF0797D11C8Q37729740-B0E387FB-FB2E-43C1-937D-D58240268676Q38292525-4FEDADB2-6054-4169-A549-218351E6D338Q38349616-215146EB-C6A6-4EF2-B6FB-465830984D4AQ38720813-3D4358B9-A4EC-4B4B-AD99-487B68217C0FQ38832323-1EE9351F-A391-477F-9382-CD26B2953F94Q38969264-F3E78BED-A70C-4558-B8C5-38B4E337D1D2Q39074816-4ACEA4E8-9303-4087-8B7C-DC664C423617Q39431690-14E645D1-3C26-4E6F-B0E0-23926C22FF81Q39460592-7FE564F0-A69A-4D05-98AA-FD83BFDB1F95Q39791587-7B2B4354-29F7-46BD-8EF7-B4AC355032BDQ40534376-3CAFA8C5-71F3-491C-98DE-D3835F84FDBEQ40612863-B47CD7D4-ED75-47AE-A4A0-7DDEF4AB9C46Q40629425-25ADDAB9-1D22-4D83-BD1F-6FBEA49C0F94Q44878674-F236BB3D-FB6B-49F9-B98A-C4A0C796C0A2Q49181990-CE61EE66-23F0-4B1F-8B98-9E4518D9FFACQ50875340-27CF210B-30E3-4DB7-8363-8AEDF65CEB9FQ53055068-804203D7-CECE-427C-9EC2-CB06F031E831Q55445418-441379C5-93D0-496D-83E3-BF02753F294C
P2860
Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Role of X-linked inhibitor of ...... nositide-3 kinase/Akt pathway.
@ast
Role of X-linked inhibitor of ...... nositide-3 kinase/Akt pathway.
@en
Role of X-linked inhibitor of ...... nositide-3 kinase/Akt pathway.
@nl
type
label
Role of X-linked inhibitor of ...... nositide-3 kinase/Akt pathway.
@ast
Role of X-linked inhibitor of ...... nositide-3 kinase/Akt pathway.
@en
Role of X-linked inhibitor of ...... nositide-3 kinase/Akt pathway.
@nl
prefLabel
Role of X-linked inhibitor of ...... nositide-3 kinase/Akt pathway.
@ast
Role of X-linked inhibitor of ...... nositide-3 kinase/Akt pathway.
@en
Role of X-linked inhibitor of ...... nositide-3 kinase/Akt pathway.
@nl
P2093
P1476
Role of X-linked inhibitor of ...... inositide-3 kinase/Akt pathway
@en
P2093
Jin Q Cheng
Michael Fraser
Xiuxian Jiang
P304
P356
10.1016/S1368-7646(02)00003-1
P577
2002-07-01T00:00:00Z